February 22, 2026
Headlines

Pfizer Secures Global Rights To China’s 3SBio’s Cancer Drug In $6 Billion Deal

Sumain Faisal01 mins

Pfizer Inc. announced Monday it has secured exclusive global rights, excluding China, to 3SBio Inc.’s bispecific antibody SSGJ-707.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News